Luigi Di Biase, Dhanunjaya J Lakkireddy, Jacopo Marazzato, Alejandro Velasco, Juan Carlos Diaz, Rachita Navara, Jonathan Chrispin, Bharath Rajagopalan, Andrea Natale, Sanghamitra Mohanty, Xiaodong Zhang, Domenico Della Rocca, Aarti Dalal, Ki Park, Jose Wiley, Wayne Batchelor, Jim W Cheung, George Dangas, Roxana Mehran, Jorge Romero
Electrophysiological and interventional procedures have been increasingly used to reduce morbidity and mortality in patients experiencing cardiovascular diseases. Although antithrombotic therapies are critical to reduce the risk of stroke or other thromboembolic events, they can nonetheless increase the bleeding hazard. This is even more true in an aging population undergoing cardiac procedures in which the combination of oral anticoagulants and antiplatelet therapies would further increase the hemorrhagic risk...
January 2, 2024: Journal of the American College of Cardiology